← Leaderboards
Leonard Duncan
Jmi Laboratories
$1,598,614
Attributed
$1,598,614
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $662K · FY2019–22$1M$750K$500K$250K$0
'19
'20
'21
'22
Funding mix
By agency
NIH$1,598,614 · 1
By mechanism
N01$1,598,614 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “In Vitro Testing”
- Leonard Freedman · Leidos Biomedical Research, Inc.$245,503,168
- Lynn Briscoe · Leidos Biomedical Research, Inc.$95,408,471
- Leonard Freedmand · Leidos Biomedical Research, Inc.$55,464,221
- Timothy Fouts · Advanced Bioscience Laboratories, Inc.$42,191,190
- Tony Moody · Duke University$34,777,314
- John Damon Chodera · Sloan-Kettering Inst Can Research$31,137,784
Research focus
In Vitro TestingContractsTherapeutic DevelopmentAdvanced DevelopmentMaintenanceAnti-Bacterial AgentsAntimicrobial ResistanceMycotoxinsToxinFungusAntifungal AgentsCombatBacteriaScreeningAntimicrobialCandidaLibrariesNatural ProductsPathogenStaphylococcus AureusIn VitroGram-Negative BacteriaAntimicrobial DrugArea
Grant awards (7)
TASK A19: IN VITRO SCREENING FOR ANTIBACTERIAL ACTIVITY AGAINST PUBLIC HEALTH DISEASE PATHOGENS$103,000
N01 · FY2022 · AI · contact PI
Task A18: Antibacterial MICs of a Gram-Negative Targeted Compound Collection$424,000
N01 · FY2021 · AI · contact PI
Task A02:Screening Natural Product Libraries for Antimicrobial Activity$409,658
N01 · FY2020 · AI · contact PI
Task A02:Screening Natural Product Libraries for Antimicrobial Activity$571,645
N01 · FY2019 · AI · contact PI
Task A05: In Vitro Testing for Antimicrobial Resistant-related Antibacterial Activity$73,500
N01 · FY2019 · AI · contact PI
TASK A06: LISTERIA MONOCYTOGENES MIC DETERMINATION$14,311
N01 · FY2019 · AI · contact PI
In Vitro Assessment for Antimicrobial Activity Support (Task Area A)$2,500
N01 · FY2019 · AI · contact PI